Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza

Vaccine

Volumn 30, Issue 39, 2012, Pages 5699-5702

  Örtqvist, Åke ^a,b   Bennet, Rutger ^c   Rinder, Malin Ryd ^d   Lindblad, Hans ^c   Eriksson, Margareta ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Children; Effectiveness; Severe pandemic influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CHILD HOSPITALIZATION; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HOSPITAL ADMISSION; HUMAN; INFANT; INFLUENZA A; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; RETROSPECTIVE STUDIES; SWEDEN; VACCINATION;

EID: 84864913561     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.009     Document Type: Article

References (30)

1. Glezen W.P. Considerations of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis 1980, 2:408-420.
2. Nair H., Brooks W.A., Katz M., Roca A., Berkley J.A., Madhi S.A., et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011, 378:1917-1930.
3. Jefferson T., Rivetti A., Harnden A., Di Pietrantonj C., Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008, CD004879.
4. Jefferson T., Smith S., Demicheli V., Harnden A., Rivetti A., Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005, 365:773-780.
5. Heinonen S., Silvennoinen H., Lehtinen P., Vainionpaa R., Ziegler T., Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis 2011, 11:23-29.
6. Black S., Nicolay U., Vesikari T., Knuf M., Del Giudice G., Della Cioppa G., et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 2011, 30:1081-1085.
7. Vesikari T., Knuf M., Wutzler P., Karvonen A., Kieninger-Baum D., Schmitt H.J., et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011, 365:1406-1416.
8. örtqvist A., Berggren I., Insulander M., de Jong B., Svenungsson B. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Clin Infect Dis 2011, 52:1203-1211.
9. Carmona A., Omenaca F., Tejedor J.C., Merino J.M., Vaman T., Dieussaert I., et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. Vaccine 2010, 28:5837-5844.
10. Roman F., Vaman T., Gerlach B., Markendorf A., Gillard P., Devaster J.M. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Vaccine 2010, 28:1740-1745.
11. Waddington C.S., Walker W.T., Oeser C., Reiner A., John T., Wilkins S., et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 2010, 340:c2649.
12. Rolfhamre P., Jansson A., Arneborn M., Ekdahl K. SmiNet-2: description of an internet-based surveillance system for communicable diseases in Sweden. Euro Surveill 2006, 11:103-107.
13. Protocol for cluster investigations to measure influenza vaccine effectiveness in the EU/EEA. Available from: 2009 [cited 19.01.12]. http://www.ecdc.europa.eu/en/publications/Publications/0912_TED_Protocol_for_Cluster_Investigations_to_Measure_Influenza_Vaccine_Effectiveness.pdf.
14. Andrews N., Waight P., Yung C.F., Miller E. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis 2011, 203:32-39.
15. Gilca R., Deceuninck G., De Serres G., Boulianne N., Sauvageau C., Quach C., et al. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children. Pediatrics 2011, 128:e1084-e1091.
16. Hardelid P., Fleming D.M., McMenamin J., Andrews N., Robertson C., SebastianPillai P., et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill 2011, 16.
17. Skowronski D.M., Janjua N.Z., De Serres G., Hottes T.S., Dickinson J.A., Crowcroft N., et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ 2011, 342:c7297.
18. Uphoff H., An der Heiden M., Schweiger B., Campe H., Beier D., Helmeke C., et al. Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009-a comparison of two methods; Germany, 2009/10. PLoS One 2011, 6:e19932.
19. van Buynder P.G., Dhaliwal J.K., van Buynder J.L., Couturier C., Minville-Leblanc M., Garceau R., et al. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza Other Respir Viruses 2010, 4:171-178.
20. Bate J., Yung C.F., Hoschler K., Sheasby L., Morden J., Taj M., et al. Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. Clin Infect Dis 2010, 51:e95-e104.
21. Goossen G.M., Kremer L.C., van de Wetering M.D. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev 2009, CD006484.
22. Griffin M.R., Monto A.S., Belongia E.A., Treanor J.J., Chen Q., Chen J., et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011, 6:e23085.
23. Scheifele D.W., Ward B.J., Dionne M., Vanderkooi O., Langley J.M., Dobson S., et al. Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children. Pediatr Infect Dis J 2011, 30:402-407.
24. Broos N., van Puijenbroek E.P., van Grootheest K. Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the Netherlands. Drug Saf 2010, 33:1109-1115.
25. Topley W.W.C. The role of active or passive immunisation in the control of enteric infection. Lancet 1938, 181-186.
26. Sood S.K., Daum R.S. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Pediatrics 1990, 85:698-704.
27. Jordan W.S., Badger G.F., Dingle J.H. A study of illness in a group of Cleveland families, XVI. The epidemiology of influenza, 1948-1953. Am J Hyg 1958, 68:169-189.
28. Piedra P.A., Gaglani M.J., Kozinetz C.A., Herschler G.B., Fewlass C., Harvey D., et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007, 120:e553-e564.
29. Puig-Barbera J., Arnedo-Pena A., Pardo-Serrano F., Tirado-Balaguer M.D., Perez-Vilar S., Silvestre-Silvestre E., et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain, a test-negative, hospital-based, case-control study. Vaccine 2010, 28:7460-7467.
30. Valenciano M., Kissling E., Cohen J.M., Oroszi B., Barret A.S., Rizzo C., et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011, 8:e1000388.